Positron makes purchase to enter radioisotope business
Molecular imaging company Positron has signed a letter of intent to buy Manhattan Isotope Technology (MIT), a strontium-82 (SR-82) product specialist, for an undisclosed amount.
Positron said it hopes the purchase will help make it a leading supplier of the SR-82 radioisotope.
Over the past five years, the growth of PET imaging has driven the market for SR-82 to where demand is now outpacing supply, according to the Positron announcement.
Fishers, Ind.-based Positron said the agreement with MIT, of Lubbock, Texas, is binding. It expects to wrap the deal in early January.
Positron said it hopes the purchase will help make it a leading supplier of the SR-82 radioisotope.
Over the past five years, the growth of PET imaging has driven the market for SR-82 to where demand is now outpacing supply, according to the Positron announcement.
Fishers, Ind.-based Positron said the agreement with MIT, of Lubbock, Texas, is binding. It expects to wrap the deal in early January.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.